Nurevo Technology Limited

Nurevo is the brand of Nurevo Technology Limited, company number SC892389.

Stage: Pre-seed. Working prototype of the data pipeline; preparing clinical validation.
Sector: Health technology, healthcare AI
Founded: June 2026
Headquarters: Edinburgh, United Kingdom
Team based in the UK, with team members internationally.
Registered office: 89/63 Holyrood Road, Edinburgh, EH8 8BA, United Kingdom
Company number: SC892389
Companies House: https://find-and-update.company-information.service.gov.uk/company/SC892389

Nurevo builds AI cognitive screening that turns a short, natural conversation into an explainable risk score for cognitive decline.

Nurevo Technology Limited is a UK health technology company building a multimodal AI platform for cognitive screening and triage. A short conversation on a phone or laptop is analysed across speech, language and facial signals to produce an explainable risk score, helping clinicians decide who needs specialist assessment first.

Nurevo Technology Limited is a UK health technology company building a multimodal AI platform for cognitive screening and triage. A short conversation on a phone or laptop is analysed across speech, language and facial signals to produce an explainable risk score, helping clinicians decide who needs specialist assessment first. The company is headquartered in Edinburgh, United Kingdom, and is registered in Scotland, company number SC892389. The registered office is 89/63 Holyrood Road, Edinburgh, EH8 8BA, United Kingdom. Nurevo was founded in June 2026. It is at pre-seed stage, with a working prototype of the data pipeline, and is preparing clinical validation.

Nurevo holds no conformity marking and no regulatory clearance. Nurevo is a screening and triage tool in development. It is not a diagnostic device and is not currently available for clinical use.

Nurevo is a screening and triage tool in development. It is not a diagnostic device and is not currently available for clinical use.

Website: https://nurevo.health
Email: info@nurevo.health
Investors: investors@nurevo.health
Media: media@nurevo.health
LinkedIn: https://www.linkedin.com/company/nurevo
Investor brief: https://nurevo.health/about#investors
Full text of the website: https://nurevo.health/llms-full.txt

Dementia, Worldwide
- 57 million people were living with dementia worldwide in 2021. Source: World Health Organization, https://www.who.int/news-room/fact-sheets/detail/dementia. Fact sheet updated 26 October 2026. The worldwide counts are for 2021.
- Nearly 10 million new cases each year. Source: World Health Organization, https://www.who.int/news-room/fact-sheets/detail/dementia. Fact sheet updated 26 October 2026. The worldwide counts are for 2021.
- More than 60% of people living with dementia live in low and middle income countries. Source: World Health Organization, https://www.who.int/news-room/fact-sheets/detail/dementia. Fact sheet updated 26 October 2026. The worldwide counts are for 2021.

Dementia, In the UK
- 982,000 people are estimated to be living with dementia in the UK. Source: Alzheimer's Society, https://www.alzheimers.org.uk/about-us/policy-and-influencing/economic-impact-of-dementia. The three UK figures are taken from this page.
- More than a third of people living with dementia in the UK have not been formally identified. Source: Alzheimer's Society, https://www.alzheimers.org.uk/about-us/policy-and-influencing/economic-impact-of-dementia. The three UK figures are taken from this page.
- 1.4 million people are expected to be living with dementia in the UK by 2040. Source: Alzheimer's Society, https://www.alzheimers.org.uk/about-us/policy-and-influencing/economic-impact-of-dementia. The three UK figures are taken from this page.


Updated: 1 November 2026